69097-844 : Alfuzosin Hydrochloride Extended Release 10 mg Oral Tablet


NDC69097-844
Labeler: Cipla USA Inc.
Product Type: Human Prescription Drug
Drug Name:  Alfuzosin Hydrochloride Extended Release
Dosage Form: Oral Tablet
Application #: ANDA090284
Rev. Date: 


Appearance:


Markings: IG;302
Shapes:  Round
Colors:  White
Size (mm): 9
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

IG 302: (31722-302) Alfuzosin Hydrochloride Extended Release 10 mg Oral Tablet by Cipla USA Inc.
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 69097-844-02: 30 TABLET IN 1 BOTTLE (69097‑844‑02)
  • 69097-844-05: 90 TABLET IN 1 BOTTLE (69097‑844‑05)
  • 69097-844-07: 100 TABLET IN 1 BOTTLE (69097‑844‑07)
  • 69097-844-12: 500 TABLET IN 1 BOTTLE (69097‑844‑12)

Active Ingredients:

  • Alfuzosin Hydrochloride

Dosage Strength:

  • 10 mg

Inactive Ingredients:

  • Cellulose, Microcrystalline
  • Guar Gum
  • Hypromelloses
  • Silicon Dioxide
  • Magnesium Stearate

Pharmaceutical Classes:

  • Adrenergic alpha-Antagonists [MoA]
  • alpha-Adrenergic Blocker [EPC]

Related Products:

Based on records with the same trade name.
  • 69189-0304 Alfuzosin Hydrochloride Extended Release 10 mg Oral Tablet by Avera Mckennan Hospital
  • 70934-961 Alfuzosin Hydrochloride Extended Release 10 mg Oral Tablet by Denton Pharma, Inc. Dba Northwind Pharmaceuticals

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 69097-844 QR Code

< Prev: 69097-843Next: 69097-845 >

Related Discussions:

Alfuzosin Information
How long do i take this medication for? ## Have you consulted your doctor? Alfuzosin is used to treat BPH and the durati... 3 replies
inactive ingredients alfuzosin
I was recently switched from Alfuzosin Hydrochloride produced by Sun to one produced by Apotex. The only difference was ... 2 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.